JPMorgan Chase & Co. Purchases 227,864 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX)
JPMorgan Chase & Co. boosted its position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 512.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 272,328 shares of the company’s stock after acquiring an additional 227,864 shares during the period. JPMorgan Chase & Co.’s holdings in Compass Therapeutics were worth $395,000 at the […]
JPMorgan Chase & Co. boosted its position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 512.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 272,328 shares of the company’s stock after acquiring an additional 227,864 shares during the period. JPMorgan Chase & Co.’s holdings in Compass Therapeutics were worth $395,000 at the […]
